All Blogs
May 31, 2022
Bristol-Myers Squibb’s Opdivo Approval; Mirati’s KRAS-inhibitor Adagrasib; J&J and Legend Biotech’s CAR-T Carvykti Approval; Roche’s Glofitamab; Arena Pharma’s Etrasimod Phase 3 Trials; FDA Approves Dermavant’s Vtama; FDA Approves Novartis’ Cell Therapy; NICE Approves Merck’s Keytruda
Bristol-Myers Squibb’s Opdivo Gets FDA Approval for Esophageal Cancer The FDA has approved two combination drug regimens based on Bristol-Myers Squibb’s PD-1 inhibitor Opdivo for previously untreated advanced Esophageal Cancer, encroaching on the territory belonging to Merck & Co’s rival Keytruda. The latest...
Read More...
May 30, 2022
Covering the Therapeutic Advancements in Obstructive Sleep Apnea Treatment Scenario
Obstructive Sleep Apnea (OSA) is a common, chronic, sleep-related breathing disorder characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to either complete or partial obstruction of the airway, resulting in apneas, hypopneas, or both. Obstructive Sleep Apnea causes day...
Read More...
May 27, 2022
Dry AMD Market: Pegcetacoplan or Zimura, Which Therapy Will Dominate the Market?
The Dry AMD market is a billion-dollar business opportunity today as around 80–90% of individuals are affected by it. As per DelveInsight analysis, there were approximately 34.9 million cases of Dry AMD in 2021. Moreover, in 10–15% of patients with Dry AMD, the deterioration is more rapid and extensive, and they su...
Read More...
May 26, 2022
Accleus’s Toro-L Interbody Fusion System; Labcorp’s New Test for Skin Cancer; SERA Prognostics’s Preterm Test; Endotronix’s SIRONA 2 Clinical Trial; Anumana’s AI Algorithm to Detect ECG Pulmonary Hypertension; Illumina’s Pan-cancer Companion Diagnostic
Accleus Receives Regulatory Approval from US FDA for Toro-L Interbody Fusion System On May 19, 2022, the US Food and Drug Administration (FDA) granted the regulatory approval to Toro-L interbody fusion system developed by Accleus. The device is a biplanar expandable lateral implant designed for a minimal inserti...
Read More...
Jul 14, 2025
The Impact of Cloud Computing in Healthcare Industry: Efficiency, Access, and Innovation
Cloud computing in healthcare has become a cornerstone of modern medical IT services, revolutionizing how medical data is stored, accessed, shared, and analyzed. The COVID-19 pandemic significantly accelerated the adoption of cloud computing in the healthcare industry, pushing hospitals, clinics, and research insti...
Read More...
May 24, 2022
PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboration with Atara; FDA Accepts Biohaven’s Zavegepant; AbbVie Files FDA Approval for ABBV-951; Innoviva to Acquire Entasis; FDA Orphan Drug Designation to XMT-2056; FDA Approves Azacitidine for Juvenile Myelomonocytic Leukemia
EU Recommends Approval for PTC Therapeutics’ Gene Therapy Upstaza Upstaza, a gene therapy developed by PTC Therapeutics for patients with the genetic condition AADC deficiency, has been recommended for EU approval, putting another test of gene therapy's commercial prospects in the union. Upstaza (eladocagene exu...
Read More...
May 23, 2022
Evaluation of the Advancing Developmental and Epileptic Encephalopathy Treatment Pipeline
Developmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are characterized both by seizures, which are often drug-resistant, as well as encephalopathy, which is a term used to describe significant developmental delay or even loss of developmental skills. In Developmental and Epil...
Read More...
Jun 19, 2026
Interpreting the Growth and Major Developments in the Medical Device Contract Manufacturing Market
Medical device contract manufacturing has evolved into one of the most dynamic and strategically critical segments of the global healthcare supply chain. As original equipment manufacturers (OEMs) and innovators face mounting pressure to accelerate time-to-market, reduce capital expenditure, and navigate an increas...
Read More...
May 19, 2022
Check-Cap’s Pivotal Trial for C-Scan; Curebase and Flow Neuroscience’s tDCS Device; Brainlab Acquires Majority Share in medPhoton; GE Healthcare to Invest in Pulsenmore; Medtronic’s Drug-Eluting Coronary Stent System; Remedee’ Endorphin Stimulation Solution;
Check-Cap Initiated the US Pivotal Trial for C-Scan® On May 11, 2022, Check-Cap Ltd., a clinical-stage diagnostic company initiated the US pivotal trial for C-Scan® at Mayo Clinic in Rochester Minnesota. C-Scan is the first and only patient-friendly, preparation-free screening test to detect polyps before they m...
Read More...
May 18, 2022
Evaluating the Major Developments in the Smart Pills Market
As our medical demands rise, so does the technology that distributes our medications. With innovative phone apps, alarms, smart packaging, and smart pills, there is no excuse to miss a dosage or forget to take your medication. With the evolution of wireless devices and microscopic cameras, the terms "embeddable" an...
Read More...